Stay updated with breaking news from Fred Schwarzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MOUNTAIN VIEW, Calif., April 10, 2024 -- IGM Biosciences, Inc. , a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief...
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) was the target of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 4,760,000 shares, an increase of 5.5% from the February 29th total of 4,510,000 shares. Based on an average daily volume of 291,100 shares, […]
Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) traded down 6.7% on Monday . The company traded as low as $9.57 and last traded at $9.60. 97,494 shares changed hands during mid-day trading, a decline of 66% from the average session volume of 286,859 shares. The stock had previously closed at $10.29. Wall […]
Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) fell 6.7% on Monday . The stock traded as low as $9.57 and last traded at $9.60. 97,494 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 286,859 shares. The stock had previously closed at $10.29. Analysts Set […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report)’s stock price was down 6% during trading on Wednesday . The stock traded as low as $15.06 and last traded at $15.11. Approximately 40,803 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 310,863 shares. The stock had previously closed […]